Consensus DexCom, Inc. Boerse Muenchen

Stocks

DC4

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Boerse Muenchen 16:43:10 2026-09-15 EDT			5-day change	1st Jan Change
75.00 ^EUR	+2.46%		-2.14%	+28.02%

09-14	DexCom Promotes CFO Jereme Sylvain to Additional COO Role	MT
09-14	Dexcom, Inc. Announces Appointment of Jereme Sylvain as Executive Vice President and Chief Operating Officer, Effective September 14, 2026	CI

494b97097ca1bf80d97f6d81c.OLhDtbO51q7a-_UyqaVPw29wfXsXXe3pZJfACgtzmGM.D_522Pv3u8-1t8ABy-EolFw2ShNYCqiYUqKpfFobqFt_ixaC3NWE6ZezrA~ab846e7e6999497fc0540b4b3f964d4a

Analysts' recommendations: DexCom, Inc.

08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
08-04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
08-03	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
08-03	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
07-31	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
07-31	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
07-31	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
07-31	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
07-31	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
07-31	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
07-31	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
07-31	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
07-31	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
07-31	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
07-31	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
07-31	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
07-31	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
07-31	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
07-31	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
07-31	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT
07-31	Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating	MT
07-31	BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating	MT
07-31	Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating	MT
07-31	Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis…
07-28	UBS Adjusts Price Target on DexCom to $96 From $95, Maintains Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+16.66%
	MEDTRONIC PLC					+11.76%
	CENCORA, INC.					+13.7%
	BECTON, DICKINSON AND COMPANY					+6.97%
	HOYA CORPORATION					+36.42%
	DEXCOM, INC.					+11.15%
	MEDLINE INC.					+36.85%
	WEST PHARMACEUTICAL SERVICES, INC.					+14.13%
	TERUMO CORPORATION					+38.82%
	Average					+20.72%
	Weighted average by Cap.					+17.58%